ADAM10 as a Biomarker for Alzheimer's Disease: A S... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

ADAM10 as a Biomarker for Alzheimer's Disease: A Study with Brazilian Elderly

Full text
Author(s):
Manzine, Patricia Regina [1] ; de Franca Bram, Jessyka Maria [1] ; Barham, Elisabeth Joan [2] ; Carvalho do Vale, Francisco de Assis [3] ; Selistre-de-Araujo, Heloisa Sobreiro [4] ; Cominetti, Marcia Regina [1] ; Iost Pavarini, Sofia Cristina [1]
Total Authors: 7
Affiliation:
[1] Univ Fed Sao Carlos, Dept Gerontol, BR-13565905 Sao Carlos, SP - Brazil
[2] Univ Fed Sao Carlos, Dept Psicol, BR-13565905 Sao Carlos, SP - Brazil
[3] Univ Fed Sao Carlos, Dept Med, BR-13565905 Sao Carlos, SP - Brazil
[4] Univ Fed Sao Carlos, Dept Ciencias Fisiol, BR-13565905 Sao Carlos, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS; v. 35, n. 1-2, p. 58-66, 2013.
Web of Science Citations: 18
Abstract

Alzheimer's disease (AD) is the most common cause of dementia in people above age 65. Platelet studies with ADAM10 have shown that its expression is reduced in AD patients. The aim of this research was to compare the platelet levels of ADAM10 protein in two Brazilian elderly groups, considering the stages of the disease. The SDS-PAGE technique followed by Western blotting was used. Data were analyzed using comparison, correlation and association statistical methods. The results showed reduced platelet ADAM10 levels in AD elderly compared to non-AD subjects. The disease progression intensified this reduction. ADAM10 was the only statistically significant variable (p = 0.01) to increase the AD occurrence probability. The cutoff value of 0.4212 in the receiver operating characteristic curve captured sensitivity and specificity of 70 and 80.77%, respectively. Together with other clinical criteria, ADAM10 seems to be a relevant biomarker tool for early and accurate AD diagnosis. Copyright (C) 2013 S. Karger AG, Basel (AU)

FAPESP's process: 10/09497-7 - Platelet levels of ADAM10 in tracking Alzheimer's disease: contributions for nursing care
Grantee:Sofia Cristina Iost Pavarini
Support Opportunities: Regular Research Grants
FAPESP's process: 12/22529-0 - ADAM10 as a biomarker for Alzheimer's Disease: a study with Brazilian elderly
Grantee:Márcia Regina Cominetti
Support Opportunities: Regular Research Grants - Publications - Scientific article